Albumin-bilirubin score indicates liver fibrosis staging and prognosis in patients with chronic hepatitis C

被引:42
作者
Fujita, Koji [1 ]
Oura, Kyoko [1 ]
Yoneyama, Hirohito [1 ]
Shi, Tingting [1 ]
Takuma, Kei [1 ]
Nakahara, Mai [1 ]
Tadokoro, Tomoko [1 ]
Nomura, Takako [1 ]
Morishita, Asahiro [1 ]
Tsutsui, Kunihiko [1 ]
Himoto, Takashi [2 ]
Masaki, Tsutomu [1 ]
机构
[1] Kagawa Univ, Fac Med, Dept Gastroenterol & Neurol, Miki, Kagawa, Japan
[2] Kagawa Prefectural Univ Hlth Sci, Dept Med Technol, Takamatsu, Kagawa, Japan
关键词
hepatitis C; chronic; hepatocellular carcinoma; liver cirrhosis; prognosis; SIMPLE NONINVASIVE INDEX; HEPATOCELLULAR-CARCINOMA; PLUS RIBAVIRIN; BIOPSY; PEGINTERFERON; ELASTOGRAPHY; INFECTION; CIRRHOSIS; DISEASE; MARKERS;
D O I
10.1111/hepr.13333
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim Albumin-bilirubin (ALBI) grade was investigated to predict prognosis of patients with cirrhosis. It was defined using the ALBI score calculated based on serum total bilirubin and albumin, which represent liver function. The diagnostic accuracy for liver fibrosis staging in patients with chronic hepatitis using the ALBI score has not been investigated well. This study aimed to evaluate the diagnostic abilities of the ALBI score for liver fibrosis staging in chronic hepatitis and cirrhosis in Japanese patients with hepatitis C virus (HCV) infection. Methods Japanese patients with HCV infection who underwent liver biopsy examinations were enrolled in a retrospective study. Fibrosis staging and activity grading were assessed using the modified METAVIR score. The ALBI score was calculated according to the following equation: Log10 total bilirubin (mu mol/L) x 0.66 + albumin (g/L) x (-0.085). Results A total of 382 patients were enrolled in this study. The ALBI score differentiated fibrosis stage 4 from 3 and stage 3 from 2 (P < 0.05). When an ALBI score of -2.125 was adopted as a cut-off value, the sensitivity and specificity were 73.2% and 87.1%, respectively, with a positive likelihood ratio of 5.67 to differentiate stage 4 from stages 1-3. Kaplan-Meier analysis showed that smaller ALBI scores at baseline correlated with better hepatocellular carcinoma (HCC)-free and overall survival (P < 0.05). Conclusions The ALBI score indicates liver fibrosis staging in Japanese patients with HCV infection. Furthermore, smaller ALBI scores predict better HCC-free survival and overall survival. The ALBI score has the potential to expand its application from cirrhosis to chronic hepatitis.
引用
收藏
页码:731 / 742
页数:12
相关论文
共 39 条
[1]   DIAGNOSTIC-TESTS-3 - RECEIVER OPERATING CHARACTERISTIC PLOTS .7. [J].
ALTMAN, DG ;
BLAND, JM .
BRITISH MEDICAL JOURNAL, 1994, 309 (6948) :188-188
[2]   Shear-Wave Elastography of the Breast: Value of a Quality Measure and Comparison with Strain Elastography [J].
Barr, Richard G. ;
Zhang, Zheng .
RADIOLOGY, 2015, 275 (01) :45-53
[3]   Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges [J].
Baumert, Thomas F. ;
Berg, Thomas ;
Lim, Joseph K. ;
Nelson, David R. .
GASTROENTEROLOGY, 2019, 156 (02) :431-445
[4]   An algorithm for the grading of activity in chronic hepatitis C [J].
Bedossa, P ;
Poynard, T .
HEPATOLOGY, 1996, 24 (02) :289-293
[5]  
BEDOSSA P, 1994, HEPATOLOGY, V20, P15
[6]   Current concepts: Liver biopsy. [J].
Bravo, AA ;
Sheth, SG ;
Chopra, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (07) :495-500
[7]  
Carling U, 2018, ACTA RADIOL, V11
[8]   Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection A Systematic Review [J].
Chou, Roger ;
Wasson, Ngoc .
ANNALS OF INTERNAL MEDICINE, 2013, 158 (11) :807-+
[9]   Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease [J].
Colloredo, G ;
Guido, M ;
Sonzogni, A ;
Leandro, G .
JOURNAL OF HEPATOLOGY, 2003, 39 (02) :239-244
[10]   COMPARING THE AREAS UNDER 2 OR MORE CORRELATED RECEIVER OPERATING CHARACTERISTIC CURVES - A NONPARAMETRIC APPROACH [J].
DELONG, ER ;
DELONG, DM ;
CLARKEPEARSON, DI .
BIOMETRICS, 1988, 44 (03) :837-845